指南与共识湿疹皮炎与荨麻疹

特应性湿疹临床症状的临床实践测量:HOME临床实践倡议首份共识声明

Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative.
指南 / 共识 · J Am Acad Dermatol · 2020-01-08

HOME小组通过在线调查对21个健康域进行优先级排序,确定患者报告症状为最高优先级域,并在HOME VI会议上经共识推荐临床实践中使用POEM、PO-SCORAD指数或两者联合测量特应性湿疹症状,瘙痒数字评定量表待定义和验证后支持使用。

要点

  • 临床实践中测量特应性湿疹症状推荐使用POEM、PO-SCORAD指数或两者联合。
  • 患者报告症状是特应性湿疹临床实践中最优先测量的健康域。
  • 瘙痒数字评定量表需待定义和验证后方可在特应性湿疹中支持使用。

核心结论

  • 推荐在临床实践中使用POEM、PO-SCORAD指数或两者联合测量特应性湿疹症状。

研究设计与样本

  • HOME小组在线调查成员识别并排序21个可能的健康域,随后在HOME VI会议上采用基于仪器质量系统评价的共识流程选择合适测量工具。

主要发现

  • 患者报告症状是最高优先级的健康域。
  • 根据心理测量学特性和可行性,共识推荐POEM、PO-SCORAD指数或两者联合用于临床实践测量特应性湿疹症状。
  • 瘙痒数字评定量表获得支持,但需待定义和验证后方可在特应性湿疹中使用。

关键数值与推荐

  • 在线调查识别并排序了21个可能的健康域。
  • 最高优先级域为患者报告症状。
  • 推荐测量工具为POEM、PO-SCORAD指数或两者联合。

临床怎么用

  • 临床实践中可采用POEM、PO-SCORAD指数或两者联合记录特应性湿疹患者报告症状。
  • 瘙痒数字评定量表目前不宜常规用于特应性湿疹,需待定义和验证。

局限性

  • 瘙痒数字评定量表在特应性湿疹中的使用需待定义和验证。
  • 其他高优先级健康域将在后续HOME会议上评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Measuring patient-centered outcomes in clinical practice is valuable for monitoring patients and advancing real-world research. A new initiative from the Harmonising Outcome Measures for Eczema (HOME) group aims to recommend what might be recorded for atopic eczema patients in routine clinical care. OBJECTIVES: Prioritize outcome domains to measure atopic eczema in clinical practice and select valid and practical outcome measurement instruments for the highest-priority domain. METHODS: An online survey of HOME members identified and ranked 21 possible health domains. Suitable instruments were then selected for the top-prioritized domain at the HOME VI meeting, using established consensus processes informed by systematic reviews of instrument quality. RESULTS: Patient-reported symptoms was the top-prioritized domain. In accordance with psychometric properties and feasibility, there was consensus that the recommended instruments to measure atopic eczema symptoms in clinical practice are the POEM, the PO-SCORAD index, or both. The numeric rating scale for itch received support pending definition and validation in atopic eczema. CONCLUSION: Following the first step of the HOME Clinical Practice initiative, we endorse using the POEM, the PO-SCORAD index, or both for measuring atopic eczema symptoms in clinical practice. Additional high-priority domains for clinical practice will be assessed at subsequent HOME meetings.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Leshem YA, Chalmers JR, Apfelbacher C, et al. Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative. J Am Acad Dermatol. 2020. PMID: 31926221. doi:10.1016/j.jaad.2019.12.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。